The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide: BPC 157 & TB 500 in The Colony TX Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law FDA to weigh easing limits on unproven peptides RFK Jr. and the Perils of Peptides Washington Monthly